BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Moxalactam

the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.

300+ PubMed studies analyzed · 51 RCTs · Evidence Score: 48.4

Research Domains

Moxalactam has been studied across 9 research domains including 🫘 Kidney, 😴 Sleep, 🫁 Respiratory, 🧠 Focus & Attention, 🔬 Oncology. The primary research focus is 🫘 Kidney with 8% of studies addressing this area.

Loading evidence profile...

This evidence profile for Moxalactam is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.